- Drugs
- Friday, 15 May 2020
Sanofi says COVID-19 vaccine will be available globally at the same time
Sanofi will ensure that a potential vaccine against COVID-19, if approved, reaches all regions of the world at the same time, the chairman of the French drugmaker said on Thursday.
“There will be no particular advance given to any country,” Serge Weinberg told France 2 television.
“We are organised with several manufacturing units. Some of them are in the United States but even more of them are in Europe and France,” he said.
Sanofi operates 73 industrial locations in 32 countries. There is no vaccine approved yet against COVID-19, the illness caused by the new coronavirus.
The group’s chief executive Paul Hudson said on Thursday it was vital that any coronavirus vaccine reach all parts of the world, after angering the French government earlier by saying the United States would get priority access.
Related Industry Updates
Mediterranean Fish Vaccine Market is expected to reach US$ 2,09,030.80 million by 2030
Aug 10, 2023
COVID-19 Fallout Drives Major Increases for Driven's Online Cannabis Sales
Mar 17, 2020
Acne Medication Market is expected to reach US$ 11,802.29 million by 2030
Mar 04, 2024
Osteonecrosis Treatment Market is expected to reach US$ 1,021.92 million by 2030
Dec 12, 2023
Investors Hunting for Winners in Ashes of Industry Fire up Rally in Cannabis Stocks
Jan 24, 2020
Ferrocene Market Manufacturers, Industry Demand, Size, Share, Growth and Forecast Analysis to 2027
Apr 26, 2021
Applied BioMath, LLC Announces Collaboration with Northern Biologics
Apr 22, 2020
Follow us on
